Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 17, 2012

Primary Completion Date

December 5, 2014

Study Completion Date

December 5, 2014

Conditions
Cytomegalovirus (CMV)
Interventions
DRUG

Maribavir

Tablet for oral administration

Trial Locations (32)

10032

Columbia University, New York

10065

Memorial Sloan-Kettering Cancer Center, New York

15213

University of Pittsburg, Pittsburgh

19104

University of Pennsylvania, Philadelphia

19141

Albert Einstein Medical Center, Philadelphia

21205

Johns Hopkins Hospital, Baltimore

27157

Wake Forest Medical Center, Winston-Salem

29425

Medical University of South Carolina, Charleston

30322

Emory University, Atlanta

Duke University Medical Center, Durham

32610

University of Florida, Gainesville

33614

Tampa General Hospital, Tampa

37212

Vanderbilt Medical Center, Nashville

43205

Nationwide Children's Hospital, Columbus

44195

Cleveland Clinic Foundation, Cleveland

48109

University of Michigan, Ann Arbor

48202

Henry Ford Health Care System, Detroit

55454

University of Minnesota Medical Center, Minneapolis

60611

Northwestern University Medical Center, Chicago

60637

University of Chicago, Chicago

68198

University of Nebraska, Omaha

70121

Ochsner Clinic Foundation, New Orleans

78229

Methodist Healthcare System, San Antonio

80045

University of Colorado, Denver

84132

University of Utah, Salt Lake City

90095

UCLA Medical Center, Los Angeles

94305

Stanford University Medical Center, Stanford

98109

University of Washington, Seattle

98195

Fred Hutchinson Cancer Research Center, Seattle

06520

Yale University, New Haven

02115

Brigham and Women's Hospital, Boston

01655

University of Massachusetts, Worcester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT01611974 - Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients | Biotech Hunter | Biotech Hunter